Home Bio-Thera Completes Phase III Enrollment for Diabetic Macular Edema Treatment

Bio-Thera Completes Phase III Enrollment for Diabetic Macular Edema Treatment

May 28, 2026 17:18 CST Updated 18:49
Bio-Thera

Innovative Drug Developer